piclidenoson

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and EfficacyNCT06643260Can-Fite BioPharmaPhase 3Not yet recruiting2027-12Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.